Sangamo Therapeutics Inc Equity-NMS: SGMO

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$1.76

52W high :

$6.42

1Y :

-70.96%

5Y :

-90.58%

EPS(TTM): :

-1.25

Shares O/S :

168.48 M

Market cap :

286.42 M

What is the share price of Sangamo Therapeutics Inc today?

Sangamo Therapeutics Inc (SGMO) share price as of March 29, 2023, is $1.76. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Sangamo Therapeutics Inc?

Yes, Indian Investors can invest in the Sangamo Therapeutics Inc (SGMO) Share by opening an international trading account with Angel One.

How can I purchase Sangamo Therapeutics Inc shares in India?

Purchasing Sangamo Therapeutics Inc (SGMO) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Sangamo Therapeutics Inc (SGMO) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Sangamo Therapeutics Inc?

Yes, you can purchase fractional shares of Sangamo Therapeutics Inc (SGMO) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Sangamo Therapeutics Inc?

The market capitalization of Sangamo Therapeutics Inc on March 29, 2023, is $286.42 M.

In which sector Sangamo Therapeutics Inc belongs?

Sangamo Therapeutics Inc operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in Sangamo Therapeutics Inc stocks?

In order to invest in Sangamo Therapeutics Inc (SGMO) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Sangamo Therapeutics, Inc. is a clinical-stage genomic medicine company. The Company focuses on leveraging its optimized zinc finger (ZF) technology, which is a differentiated tool used to develop genomic medicines, including allogeneic cell therapies and in vivo genome engineering therapies. Its product candidates include Isaralgagene civaparvovec, also known as ST-920, its wholly owned gene therapy product candidate for the treatment of Fabry disease; TX200, its wholly owned Chimeric Antigen Receptor (CAR), engineered regulatory T cell (CAR-Treg) cell therapy product candidate for the prevention of immune-mediated rejection in HLA-A2 mismatched kidney transplantation; Giroctocogene fitelparvovec, also known as SB-525, is a gene therapy product candidate for the treatment of moderately severe to severe hemophilia A., and BIVV003, its zinc finger nuclease, or ZF nuclease, gene-edited cell therapy product candidate for the treatment of sickle cell disease (SCD).